구제역 백신 시장 보고서(2026년)
Foot And Mouth Disease Vaccine Global Market Report 2026
상품코드 : 1938662
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,691,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,672,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,652,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

구제역 백신 시장 규모는 최근, 현저한 성장을 달성하고 있습니다. 2025년 28억 3,000만 달러에서 2026년에는 31억 1,000만 달러로, CAGR 9.9%로 확대할 전망입니다. 지난 수년간의 성장은 구제역의 빈번한 발생, 가축 사육두수 증가, 정부 주도의 백신 접종 프로그램, 기존 백신 기술의 발전, 동물 위생관리에 대한 인식 증가 등이 원인으로 추정됩니다.

구제역 백신 시장 규모는 향후 수년간 급성장이 전망되고 있습니다. 2030년에는 45억 7,000만 달러에 달하며, CAGR은 10.1%에 달할 전망입니다. 예측 기간의 성장 요인으로는 신속 대응 백신 및 DIVA 백신 개발, 다품종 백신 접종 범위 확대, 오일 보조제 및 수산화알루미늄 기반 백신 채택, 구제역 대책에 대한 정부 자금 지원 증가, 콜드체인 및 유통 인프라에 대한 투자 확대 등을 꼽을 수 있습니다. 등이 있습니다. 예측 기간 중 주요 동향으로는 긴급 발생 대응을 위한 긴급 백신 도입 증가, 다품종 구제역 백신 접종 프로그램에 대한 관심 증가, DIVA(감염 동물과 백신 접종 동물 식별) 백신 개발, 정부 주도의 예방접종 캠페인 확대, 유성 보조제 및 수산화알루미늄 백신 사용 증가 등을 들 수 있습니다.

늘어나는 가축 사육두수가 구제역 백신 시장의 성장을 촉진하고 있습니다. 가축이란 소, 말, 돼지 등 인간이 사육, 관리, 이용하는 농축산물을 말합니다. 가축 수 증가는 축산물에 대한 수요 증가에 의해 촉진되고 있습니다. 가축 사육두수가 증가함에 따라 구제역 확산 위험이 높아져 시장 성장을 가속할 수 있습니다. 예를 들어 2023년 7월 유엔의 미국 기관인 FAO가 발표한 바에 따르면 2023년 세계 우유 생산량은 9억 4,400만 톤에 달할 것으로 예상되며, 2022년 대비 0.9% 증가할 것으로 전망하고 있습니다. 이는 소득 향상과 단백질 중심의 식생활로의 전환에 따라 동물성 식품에 대한 수요가 증가하고 있음을 반영합니다. 따라서 가축 사육두수 증가는 구제역 백신 시장 성장 촉진요인이 될 것으로 예측됩니다.

헬스케어 지출 증가도 구제역 백신 시장의 성장을 가속할 것으로 예측됩니다. 헬스케어 지출은 특정 기간 중 헬스케어 관련 상품 및 서비스에 대한 총 지출을 의미합니다. 헬스케어에 대한 투자 증가는 수의학 분야의 연구개발을 지원하고, 동물의 구제역 예방 등 보다 효과적이고 진보된 백신을 개발할 수 있도록 돕습니다. 예를 들어 프랑스에 본부를 둔 정부 간 경제협력개발기구(OECD)에 따르면 2025년 11월 기준, 회원국의 보건의료제도는 2024년 GDP의 평균 9.3%를 보건의료에 지출할 것으로 예상되며, 실질 1인당 지출은 2023년 정체기를 거쳐 다시 증가 추세를 보일 것으로 전망하고 있습니다. 1인당 평균 지출은 연간 3% 이상의 성장률을 보이고 있습니다. 그 결과, 헬스케어 비용 증가가 구제역 백신 시장 확대를 견인하고 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA
영문 목차

영문목차

Foot-and-mouth disease (FMD) vaccines serve as a crucial intervention to enhance the immune defenses of animals against the highly contagious foot-and-mouth disease. This disease poses a severe threat to all cloven-hoofed animals, including cattle, sheep, goats, camelids, deer, and pigs. Clinical signs of FMD in animals include elevated body temperature and the development of blisters, primarily affecting the feet and mouth.

The main categories of foot-and-mouth disease vaccines include conventional vaccines, oil-based vaccines, aluminum hydroxide/saponin-based vaccines, and emergency vaccines tailored for cattle, pigs, sheep, goats, and other susceptible animals. Conventional vaccines typically consist of inactivated disease-causing organisms or pathogen-derived proteins (antigens). These antigens mimic the infectious agent, working to stimulate the immune system. The goal is to prime the immune system, enabling it to respond more rapidly and effectively if the animal is exposed to the actual infectious agent. Distribution channels for foot-and-mouth disease vaccines are diverse and include government organizations, distributors/pharmacies, private veterinary services, and other relevant distribution channels. This widespread availability ensures that these vaccines can be efficiently disseminated to protect susceptible animal populations and prevent the spread of foot-and-mouth disease.

Tariffs have impacted the foot-and-mouth disease vaccine market by raising import costs of vaccine ingredients, adjuvants, and delivery systems, particularly affecting regions such as Asia-Pacific and Africa where FMD prevalence is high. Livestock and multi-species vaccination programs are most affected. Positive impacts include encouraging local production of vaccines and promoting domestic research and development for more cost-effective and readily available vaccine solutions.

The foot and mouth disease vaccine market research report is one of a series of new reports from The Business Research Company that provides foot and mouth disease vaccine market statistics, including foot and mouth disease vaccine industry global market size, regional shares, competitors with a foot and mouth disease vaccine market share, detailed foot and mouth disease vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the foot and mouth disease vaccine industry. This foot and mouth disease vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The foot and mouth disease vaccine market size has grown strongly in recent years. It will grow from $2.83 billion in 2025 to $3.11 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to frequent outbreaks of foot-and-mouth disease, increasing livestock population, government-led vaccination programs, advancements in conventional vaccine technologies, rising awareness of animal health management.

The foot and mouth disease vaccine market size is expected to see rapid growth in the next few years. It will grow to $4.57 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to development of rapid response and diva vaccines, expansion of multi-species vaccination coverage, adoption of oil-adjuvanted and aluminum hydroxide-based vaccines, increasing government funding for FMD control, rising investments in cold chain and distribution infrastructure. Major trends in the forecast period include increasing adoption of emergency vaccines for rapid outbreak response, rising focus on multi-species fmd vaccination programs, development of diva (differentiating infected from vaccinated animals) vaccines, expansion of government-led immunization campaigns, growing use of oil-adjuvanted and aluminum hydroxide-based vaccines.

The expanding livestock population is driving the growth of the foot and mouth disease vaccine market. Livestock refers to farm animals raised, housed, and utilized by humans, including cows, horses, and pigs. The rise in livestock numbers is driven by increased demand for animal products. As livestock populations grow, the risk of foot and mouth disease prevalence rises, which can boost market growth. For example, in July 2023, according to the FAO, a US-based United Nations agency, global milk production in 2023 was projected to reach 944 million tonnes, up 0.9% from 2022, reflecting increasing demand for animal-source foods as incomes rise and diets shift toward protein. Therefore, the growing livestock population is expected to propel the foot and mouth disease vaccine market.

The rise in healthcare expenditure is also anticipated to drive the growth of the foot and mouth disease vaccine market. Healthcare expenditure refers to the total spending on healthcare goods and services within a specific period. Increased healthcare investment supports research and development in veterinary medicine, enabling the creation of more effective and advanced vaccines, including those for preventing foot and mouth disease in animals. For instance, in November 2025, according to the Organisation for Economic Co-operation and Development (OECD), a France-based intergovernmental economic organization, healthcare systems in member countries allocated an average of 9.3% of GDP to health in 2024, with real per capita spending showing renewed growth after stagnation in 2023, and average spending per person exceeding 3% annual growth. Consequently, rising healthcare expenditure is driving the expansion of the foot and mouth disease vaccine market.

Leading players in the foot and mouth disease vaccine market are developing innovative initiatives, such as clinical trials, to enhance their market presence and profitability. Clinical trials are research studies that test new treatments and medications. For example, in June 2023, the Department of Animal Husbandry and Dairying, an India-based ministry, launched the third phase of FMD vaccination under NADCP. This phase represents a comprehensive effort to control FMD in cattle and forms part of a broader plan to manage FMD through vaccination by 2025, with the goal of eradication by 2030. The initiative also aims to improve local production and expand exports of milk and other animal products.

Major companies operating in the foot and mouth disease vaccine market are Godrej Agrovet Limited, Biogenesis Bago S.A., Indian Immunologicals Limited, Merck & Co. Inc., Intervet India Private Limited, China Animal Husbandry Group, C.H. Boehringer Sohn AG & Co. KG, FGBI-ARRIAH, NAVETCO NATIONAL VETERINARY JOINT STOCK COMPANY, Ceva Sante Animale, Alivira Animal Health Limited, Zoetis Inc., Dong Bang Co. Ltd., The Spirit Jinyu Biological Pharmaceutical Co. Ltd., Biovet Private Limited, MEVAC, SPIC Gene Science Technology Development Co. Ltd., VETAL Animal Health Products Inc., Southern Cross Group, VECOL S.A, Limor de Colombia

Asia-Pacific was the largest region in the foot and mouth disease vaccine market in 2025. The regions covered in the foot and mouth disease vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the foot and mouth disease vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The foot and mouth disease vaccine market consist of sales of inactivated vaccine, viral vector vaccine, adenovirus, virus-like particle vaccines, baculovirus, plant-produced empty capsids, RNA vaccine, and DNA vaccine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Foot And Mouth Disease Vaccine Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses foot and mouth disease vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for foot and mouth disease vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The foot and mouth disease vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Foot And Mouth Disease Vaccine Market Characteristics

3. Foot And Mouth Disease Vaccine Market Supply Chain Analysis

4. Global Foot And Mouth Disease Vaccine Market Trends And Strategies

5. Foot And Mouth Disease Vaccine Market Analysis Of End Use Industries

6. Foot And Mouth Disease Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Foot And Mouth Disease Vaccine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Foot And Mouth Disease Vaccine Total Addressable Market (TAM) Analysis for the Market

9. Foot And Mouth Disease Vaccine Market Segmentation

10. Foot And Mouth Disease Vaccine Market Regional And Country Analysis

11. Asia-Pacific Foot And Mouth Disease Vaccine Market

12. China Foot And Mouth Disease Vaccine Market

13. India Foot And Mouth Disease Vaccine Market

14. Japan Foot And Mouth Disease Vaccine Market

15. Australia Foot And Mouth Disease Vaccine Market

16. Indonesia Foot And Mouth Disease Vaccine Market

17. South Korea Foot And Mouth Disease Vaccine Market

18. Taiwan Foot And Mouth Disease Vaccine Market

19. South East Asia Foot And Mouth Disease Vaccine Market

20. Western Europe Foot And Mouth Disease Vaccine Market

21. UK Foot And Mouth Disease Vaccine Market

22. Germany Foot And Mouth Disease Vaccine Market

23. France Foot And Mouth Disease Vaccine Market

24. Italy Foot And Mouth Disease Vaccine Market

25. Spain Foot And Mouth Disease Vaccine Market

26. Eastern Europe Foot And Mouth Disease Vaccine Market

27. Russia Foot And Mouth Disease Vaccine Market

28. North America Foot And Mouth Disease Vaccine Market

29. USA Foot And Mouth Disease Vaccine Market

30. Canada Foot And Mouth Disease Vaccine Market

31. South America Foot And Mouth Disease Vaccine Market

32. Brazil Foot And Mouth Disease Vaccine Market

33. Middle East Foot And Mouth Disease Vaccine Market

34. Africa Foot And Mouth Disease Vaccine Market

35. Foot And Mouth Disease Vaccine Market Regulatory and Investment Landscape

36. Foot And Mouth Disease Vaccine Market Competitive Landscape And Company Profiles

37. Foot And Mouth Disease Vaccine Market Other Major And Innovative Companies

38. Global Foot And Mouth Disease Vaccine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Foot And Mouth Disease Vaccine Market

40. Foot And Mouth Disease Vaccine Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기